Harvard Bioscience Inc (HBIO)
3.56
-0.13
(-3.52%)
USD |
NASDAQ |
Apr 25, 16:00
3.61
+0.05
(+1.40%)
Pre-Market: 20:00
Harvard Bioscience Gross Profit (Quarterly): 16.32M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 16.32M |
September 30, 2023 | 14.73M |
June 30, 2023 | 16.67M |
March 31, 2023 | 18.35M |
December 31, 2022 | 15.83M |
September 30, 2022 | 12.17M |
June 30, 2022 | 16.64M |
March 31, 2022 | 16.18M |
December 31, 2021 | 19.56M |
September 30, 2021 | 16.31M |
June 30, 2021 | 16.35M |
March 31, 2021 | 15.43M |
December 31, 2020 | 17.71M |
September 30, 2020 | 13.50M |
June 30, 2020 | 13.86M |
March 31, 2020 | 12.98M |
December 31, 2019 | 17.23M |
September 30, 2019 | 14.98M |
June 30, 2019 | 15.96M |
March 31, 2019 | 16.15M |
December 31, 2018 | 18.74M |
September 30, 2018 | 15.82M |
June 30, 2018 | 15.36M |
March 31, 2018 | 13.27M |
December 31, 2017 | 11.02M |
Date | Value |
---|---|
September 30, 2017 | 9.50M |
June 30, 2017 | 9.073M |
March 31, 2017 | 9.577M |
December 31, 2016 | 12.10M |
September 30, 2016 | 11.69M |
June 30, 2016 | 11.68M |
March 31, 2016 | 12.94M |
December 31, 2015 | 12.92M |
September 30, 2015 | 11.73M |
June 30, 2015 | 12.60M |
March 31, 2015 | 11.48M |
December 31, 2014 | 13.86M |
September 30, 2014 | 11.44M |
June 30, 2014 | 12.28M |
March 31, 2014 | 11.76M |
December 31, 2013 | 12.05M |
September 30, 2013 | 11.30M |
June 30, 2013 | 12.09M |
March 31, 2013 | 12.26M |
December 31, 2012 | 13.33M |
September 30, 2012 | 11.99M |
June 30, 2012 | 13.62M |
March 31, 2012 | 13.40M |
December 31, 2011 | 13.16M |
September 30, 2011 | 11.88M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
12.17M
Minimum
Sep 2022
19.56M
Maximum
Dec 2021
15.83M
Average
16.18M
Median
Mar 2022
Gross Profit (Quarterly) Benchmarks
Bruker Corp | 430.30M |
Azenta Inc | 61.51M |
Bionano Genomics Inc | 2.438M |
Akoya Biosciences Inc | 16.62M |
Singular Genomics Systems Inc | -0.457M |